BASEBiological Archive
for Science & Education
Search
HomeExploreInclisiran And PCSK9 RNA interference
Drug

Inclisiran And PCSK9 RNA interference

Inclisiran and PCSK9 RNA interference

A PCSK9-targeting siRNA example that reduces production of the PCSK9 protein in the liver.

Overview

EXPLORE BY LEVEL

Inclisiran is an siRNA designed to lower PCSK9 production in the liver. It acts on the RNA message before the PCSK9 protein is made.

Quick Facts

AT A GLANCE
Explore nextMolecular medicine

Follow the Connections

See how Inclisiran And PCSK9 RNA interference links to other biological records.

Open network
ProteinPCSK9reduces mrna forTherapysiRNA Therapeuticsis a
All 3 Structured Connections
Inclisiran And PCSK9 RNA interference · DrugREDUCES MRNA FOR →PCSK9 · Protein
Inclisiran And PCSK9 RNA interference · DrugIS A →siRNA Therapeutics · Therapy
Inclisiran And PCSK9 RNA interference · DrugREDUCES MRNA FOR →PCSK9 · Protein

Recommended Reading

Trusted references for learning more about Inclisiran And PCSK9 RNA interference.

articleInclisiran in Patients at High Cardiovascular Risk with Elevated LDL CholesterolPubMed · PMID 28306389 reviewMechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesPubMed Central
Research Claims

Inclisiran illustrates how tissue-targeted siRNA can provide durable transcript reduction. Clinical interpretation requires distinguishing pharmacodynamic LDL changes from trial outcomes and current treatment guidance.